Neurocrine Bioscience buy Raymond James
Start price
01.11.23
/
50%
€105.50
Target price
01.11.24
€137.63
Performance (%)
22.70%
Price
21.05.24
€129.45
Summary
This prediction is currently active. The prediction currently has a performance of 22.70%. This prediction currently runs until 01.11.24. The prediction end date can be changed by Raymond_James at any time. Raymond_James has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Neurocrine Bioscience | 1.172% | 1.172% |
iShares Core DAX® | -0.268% | 5.471% |
iShares Nasdaq 100 | 1.854% | 7.851% |
iShares Nikkei 225® | 0.284% | 1.729% |
iShares S&P 500 | 1.178% | 5.269% |
Comments by Raymond_James for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Raymond James from $135.00 to $145.00. They now have an "outperform" rating on the stock.
Ratings data for NBIX provided by MarketBeat